Medical Research Networx

Beacon Clinical Research specializes in Phase II-IV clinical trials and is a multi-specialty site. BCR has provided research services to the pharmaceutical industry for ten years. Pharmaceutical companies such as Abbott, GSK, Merck, and Pfizer have worked with BCR in conducting various clinical drug trials, including diabetes, constipation, hypertension, hyperlipidemia, osteoarthritis, and many others. Our staff is comprised of welcoming experienced investigators, registered nurses, and coordinators who specialize in clinical research.Our continual diligence and compliance of GCP Guidelines is why BCR has such high sponsor retention within the industry. With our expertise continuing throughout each trial, we provide full execution of protocol with complete and accurate data; leaving patients and pharmaceutical contacts confident in and satisfied with our services.

Adams Clinical Trials LLC, located in Watertown, MA, is dedicated to advancing medical research through clinical trials. They provide opportunities for participants to engage in various studies while also offering sponsors an array of essential services. The organization is committed to keeping potential participants informed about new studies, updating their offerings weekly. Individuals interested in participating can easily reach out via a straightforward inquiry process to learn more about available clinical trials. Generated from the website

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.